Etrasimod for the treatment of ulcerative colitis.

Document type :
Article dans une revue scientifique: Article de synthèse/Review paper
DOI :
10.2217/imt-2022-0255
PMID :
36789612
Permalink :
http://hdl.handle.net/20.500.12210/105687
Title :
Etrasimod for the treatment of ulcerative colitis.
Author(s) :
Wils, Pauline [Auteur]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Institute for Translational Research in Inflammation - U 1286 [INFINITE]
Peyrin-Biroulet, Laurent [Auteur]
Centre Hospitalier Régional Universitaire de Nancy [CHRU Nancy]
Centre Hospitalier Universitaire de Nancy [CHU Nancy]
Journal title :
Immunotherapy
Abbreviated title :
Immunotherapy
Publication date :
2023-02-16
ISSN :
1750-7448
English keyword(s) :
etrasimod
inflammatory bowel disease
S1PR modulator
sphingosine-1-phosphate
ulcerative colitis
English abstract : [en]
Sphingosine-1-phosphate (S1P) and its receptor (S1PR) are involved in the pathogenesis of multiple immune-mediated inflammatory disorders, including inflammatory bowel disease. The use of S1PR modulators represents a new ...
Show more >
Language :
Anglais
Audience :
Internationale
Popular science :
Non
Administrative institution(s) :
Université de Lille
Inserm
CHU Lille
Collections :
Submission date :
2024-02-01T22:06:48Z
2024-03-07T13:57:28Z
Version history
VersionLinkModification date
220.500.12210/105687*2024-03-07T13:55:45Z
120.500.12210/105687.12024-02-01T22:06:48Z

*Selected version